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Abstract
Importance: Artificial Intelligence (AI) is necessary to address the
large and growing deficit in retina and healthcare access globally. Mobile
AI diagnostic platforms running in the Cloud may effectively and effi-
ciently distribute such AI capability.
Objective: To evaluate the feasibility of Cloud-based mobile artificial
intelligence for detection of retinal disease. And to evaluate the accuracy
of a particular such system for detection of subretinal fluid (SRF) and
macula edema (ME) on OCT scans.
Design: A multicenter retrospective image analysis was conducted in
which board-certified ophthalmologists with fellowship training in retina
evaluated OCT images of the macula. They noted the presence or absence
of macula edema or subretinal fluid, then compared their assessment to
that obtained from Fluid Intelligence, a mobile AI app that detects SRF
and ME on OCT scans.
Setting: Clinic setting with PACS access to OCT images of patients
with or without retinal fluid.
Participants: Board-certified ophthalmologists with fellowship train-
ing in retina retrospectively selected retinal OCT images in a consecu-
tive fashion. Effort was made by each center to balance the number of
scans with retinal fluid and scans without. Exclusion criteria included
poor quality scans, ambiguous or overly subtle features, macula holes,
retinoschisis, and dense epiretinal membranes.
Main outcome and Measures: Accuracy in the form of sensitiv-
ity and specificity of the AI mobile app compared against assessments of
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board-certified retina specialists.
Results: At the time of this submission, five centers have completed
their initial studies. This consists of a total of 283 OCT scans of which
155 had either ME or SRF (“wet”) and 128 did not (“dry”). The sensi-
tivity ranged from 82.5% to 97% with a weighted average of 89.3%. The
specificity ranged from 52% to 100% with a weighted average of 81.23%.
Conclusion and Relevance: Cloud-based Mobile artificial intelli-
gence technology is feasible for the detection retinal disease. In particular,
Fluid Intelligence (alpha version), is sufficiently accurate as a screening
tool for SRF and ME, especially in underserved areas. Further studies
and technology development is indicated.
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1 Introduction
Artificial intelligence will play a central role in screening of retinal diseases. And
mobile devices are an important modality through which diagnostic capability
can be distributed via the Cloud to areas of need. Currently it is estimated
that there are under 3000 retina specialists in the U.S. for its population of
approximately 329.25 million people as of July 1st 2018 (U.S. Census Bureau).4
Furthermore, the retina specialists are clustered in urban centers, and are few
and far between in the rural and non-coastal states. For instance, it is estimated
that the entire state of Wyoming has only two retina specialists in residence.
And as a result of this uneven distribution of specialized care, there are sev-
eral severely underserved areas of the U.S. The numbers are even more dire for
most other countries of the world. For instance, it is estimated that, Nigeria,
Africa’s most populous country has less than 10 fellowship-trained retina spe-
cialists in practice for a population of 190 million people. While Bolivia has
only one. This severe shortage of retina care is a global problem that cannot
be adequately solved by training more physicians alone. The Association of
American Medical Colleges (AAMC) projects that the problem is worsening.
A 2018 AAMC report16 projects a shortfall of up to 121,300 physicians in the
U.S. by 2030, and up to 72,700 of that shortage could be specialists. Therefore
AI is clearly a needed supplement to the retina care system and to the health-
care system in general. One important problem to solve, however, is the means
and mechanism via which AI-driven diagnostic capability will be distributed
to the areas where it is most needed. Fluid Intelligence to our knowledge is
the first mobile AI app for for eye care providers. It is an assist device for
diagnosing the presence or absence of macula edema or subretinal fluid. The
mobile app platform provides a ubiquitously available modality whose reach is
global. And this app presents an opportunity to assess the feasibility of the
Mobile/Cloud-based AI distribution method. Practically, the app user points
a mobile device camera at a picture of a retinal OCT displayed on a computer
monitor or piece of paper, and then snaps a picture of that picture. The taken
picture then goes into the cloud, the engine computes a diagnosis, and returns
a response to the user. The problem of determining the presence or absence
of subretinal fluid or macula edema on OCT is an important one. Firstly, the
presence of macula edema or subretinal fluid in the macula is essentially always
indicative of pathology. It is a canonical hallmark that underlies several com-
mon retinal conditions such as diabetic macula edema,9,10,17,20,22 exudative
macula degeneration,5,8, 11,13,25 retinal vein occlusions,23 pseudophakic mac-
ula edema14,15,21,24,26 central serous chorioretinopathy,2,6, 7, 12,18 and macula-
off retinal detachments.1,3, 19,27,28 In non-obvious cases, the determination of
retinal fluid is often a diagnostic dilemma for optometrists and even general
ophthalmologists. It constitutes a frequent source of unnecessary referral, or of
non-referral where referral is indicated. In cases of unnecessary referral, the re-
sult is often unnecessary expensive and highly inconvenient long-distance travel
for elderly patients in underserved areas. It also results in over-crowding of
retina physician offices by patients who need not be there, and this limits the
capacity of retina physicians to see patients who do need to be seen. In cases
where referral is indicated but not done, the result is often outright vision loss.
In the remainder of this paper, we describe the DATUM study, a multicenter
retrospective image analysis that tests the Fluid Intelligence mobile AI app for
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detecting the presence of fluid on OCT scans of the retina. Further, we discuss
study methodology, results, and implications.
2 Methods
The iOS operating system version of the Fluid Intelligence app was used on
iPhone 6 devices. From within the app, the iPhone camera modality was used
by study investigators to take pictures of OCT scans of the retina displayed on
computer monitors. The study investigators were board-certified ophthalmolo-
gists who have completed retina fellowships (“retina specialists”). The pictures
of the OCTs were taken in anonymized fashion. Study investigators selected
images retrospectively and in consecutive fashion. Effort was made by each in-
vestigator to balance the number of OCT images with subretinal fluid (SRF) or
macula edema (ME) (“wet”) against images without SRF or ME (“dry”). Upon
selecting an image, an assessment of the image was made by the investigator,
after which the investigator used the app to determine the AI’s assessment. If
the AI app’s assessment of a “wet” image corresponded to the retina special-
ist’s, it was deemed a true positive. If the AI app was in agreement with the
retina specialist on a “dry” image, it was deemed a true negative. If the AI app
assessed an image as “wet” but the retina specialist assessed it as “dry,” it was
deemed a false positive. And if the AI app assessed an image as “dry” but the
retina specialist assessed it as “wet,” it was deemed a false negative. Investiga-
tors were at liberty to select the images provided they were in accordance with
exclusion criteria. The following types of OCT images were excluded from the
study: 1) poor quality images, 2) macula holes, 3) dense epiretinal membranes,
4) macula retinoschisis, 5) vitreomacular traction syndrome, 6) and subtle or
ambiguous images. Anonymized images were stored in the cloud and assessed
for compliance with eligibility criteria. An image eligibility check was done on
all the centers’ submissions.
Figure 1: Machine Learning Procedure
Building the mobile AI app device: A model was trained on a data set
consisting of 1 million OCT images after augmentation. The training was done
with a deep learning model with an imageNet-trained inception base, such as
illustrated in Figure 1. Transfer learning was completed after which the trained
model was hosted in the cloud. A front-end app for iOS was developed and
4
deployed into the App Store. The front-end was connected to the cloud service
to serve the trained machine learning model during inference. An intermediate
noSQL data base archived the images sent to the cloud server for inference.
3 Results
At the time of this submission, five centers had completed their initial studies.
This consists of a total of 283 OCT scans of which 155 had either ME or SRF
(“wet”) and 128 did not (“dry”). The sensitivity ranged from 82.5% to 97%
with a weighted average of 89.3%. The specificity ranged from 52% to 100%
with a weighted average of 81.23%. Table 1 and Chart 1 show sensitivities and
specificities of individual centers.
Table 1: DATUM α Study Results
Sensitivity Specificity Number wet Number dry
Center A 82.5% 66% 31 15
Center B 94% 52% 25 25
Center C 83.3% 100% 24 25
Center D 97% 100% 35 35
Center E 82.5% 75% 40 28
Center A Center B Center C Center D Center E
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4 Discussion
The severe and growing shortage of retina care access in the U.S. and globally
makes a compelling case for artificial intelligence driven supplementation and
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enhancement of care. However, discovering and developing the most effective
and efficient mechanisms by which AI-driven diagnostic capability will be dis-
tributed is essential. A mobile AI app modality could be both an effective and
efficient means of distributing AI diagnostic capability. Such a system, the first
of its kind, Fluid Intelligence, was validated here in the DATUM alpha study.
The results demonstrate that mobile AI running in the Cloud is an effective
and efficient means of distributing AI diagnostic capability. The DATUM al-
pha study initial results demonstrate a high enough sensitivity, 89.3%, to make
for a screening tool. Prior to the study, one could be justifiably skeptical that
taking a picture of an OCT displayed on a computer monitor would yield an
image of sufficient quality to make an accurate AI diagnosis. The current study
is named the alpha study as it is first in the series. As the machine learning
algorithm is further trained with more data, subsequent validation studies will
be accordingly named beta, gamma, delta, etc. One of the advantages of run-
ning the machine learning algorithm in the cloud is the ability for periodically
enhancing the algorithm’s training and updating the AI seamlessly. The sensi-
tivities found on the DATUM alpha study demonstrated a tight band of 14.5
percentage points (from 82.5% to 97%) between centers. In addition to the rea-
sonably high sensitivities across the board, the relatively narrow span adds to
the confidence that the AI app can satisfactorily detect a problem when there
is one. In contrast to the sensitivities, the specificities had a rather wide range,
spanning 48 percentage points (from 52% to 100%). The exact specificities were
52%, 66%, 75%, 100%, and 100%. The wide span of the specificities is likely
explained by image selection. The algorithm was more likely to correctly iden-
tify an image as “dry” if the image was either normal or had only moderate
structural pathology. Also if an image was grainy due to low resolution but was
still deemed to be of sufficient image quality to be eligible, such an image was
more likely to yield a false positive on the AI read. Furthermore, we observed
that False positives were more likely in images that had features commonly as-
sociated with exudative macular degeneration; features such as large confluent
druse or pigment epithelial detachments. These false positives can therefore be
‘trained out’ with increase in the size and feature diversity of our training data
set.
Figure 2: DATUM Study Group
Of note, the DATUM study group (DSG) is international with centers in over
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15 countries and growing. Though all investigators in this initial submission are
based in the U.S., subsequent studies will have more international representation
reflective of the DSG’s make up. Figure 2 shows the geographic location of
DATUM study group investigators.
5 Conclusion
Cloud-based Mobile artificial intelligence technology is feasible for the detection
of retinal disease. In particular, Fluid Intelligence (alpha version), is sufficiently
accurate as a screening tool for subretinal fluid and macula edema. This can
serve to augment and retina care in underserved areas. Further studies and
technology development are indicated; in particular, training on larger and more
feature-diverse data sets.
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